The GLP-1 World — A clear, honest guide · Stable Ecosystem

The GLP-1 World · a clear, honest guide

Understand the medication before it runs your life

The main GLP-1 medications, who makes them, how to think about them, and the myths worth ignoring — so you walk into your doctor's office informed, not anxious.

The medications

The molecules and their brands

Most GLP-1 names trace back to a handful of molecules. Here's the map.

Semaglutide
Ozempic · Wegovy · Rybelsus
Novo Nordisk
GLP-1 injection pen
Ozempic · weekly · diabetesWegovy · weekly · weightRybelsus · daily pill

The best-known GLP-1. Curbs appetite and steadies blood sugar. When it stops, appetite and weight tend to return — the exact phase this ecosystem is built for.

Tirzepatide · GLP-1 / GIP
Mounjaro · Zepbound
Eli Lilly
Dual-action GLP-1 injection pen
Mounjaro · weekly · diabetesZepbound · weekly · weight & sleep apnea

A dual-action molecule (GLP-1 and GIP), often with strong results. The same rule applies: the muscle you protect and the habits you build decide what happens after.

Liraglutide
Saxenda · Victoza
Novo Nordisk
Daily GLP-1 injection pen
Saxenda · daily · weightVictoza · daily · diabetes

An earlier, daily GLP-1. A different rhythm — same "what comes after" question the ecosystem answers.

Other agonists
Trulicity · Bydureon · Adlyxin
Eli Lilly · AstraZeneca · Sanofi
GLP-1 pen and vials
Trulicity · dulaglutideBydureon · exenatideAdlyxin · lixisenatide

The category is bigger than two names. Whatever you're on, the maintenance phase is universal — and that's our focus.

A woman calmly reviewing her notes at home — informed, not anxious

Informed, not anxious

Knowledge is what turns fear into a plan.

You don't need to become a pharmacist — just to understand enough to feel calm and in control. That's what this page, and the whole ecosystem, is here to give you.

The makers

Who's behind the medications

Two companies dominate the space, with a few others in the category.

Novo Nordisk

The Danish maker of semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Saxenda, Victoza) — the company that put GLP-1 on the map for weight.

Eli Lilly

The U.S. maker of tirzepatide (Mounjaro, Zepbound) and dulaglutide (Trulicity) — the dual-action challenger driving much of the category's momentum.

AstraZeneca

Maker of exenatide (Bydureon), one of the earlier GLP-1 options in the diabetes space.

Sanofi

Maker of lixisenatide (Adlyxin), part of the broader GLP-1 agonist family.

How to approach it

Being a smarter patient — the four moments that matter

General, plain-language orientation. None of this replaces your doctor; it helps you ask better questions.

1

Starting

Most GLP-1s begin low and step up slowly so your body adjusts. Set expectations with your prescriber — results and side effects vary widely from person to person.

2

Staying consistent

Consistency matters more than intensity. This is also the window to protect muscle and build habits — the assets that decide your "after" long before you get there.

3

Side effects

Nausea and digestive changes are common early on. Anything severe or persistent is a conversation with your doctor, not something to push through alone.

4

Preparing to stop

The most overlooked moment. The best time to prepare for life without the shot is before your last dose — which is exactly where our system begins.

Important: This page is educational information only — not medical advice, diagnosis or treatment, and not a substitute for your physician. Stable Ecosystem is independent and not affiliated with, endorsed by or sponsored by Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi or any manufacturer; brand names belong to their respective owners. Always consult a licensed healthcare provider before starting, changing or stopping any medication.

Myths vs. facts

What we correct instead of exploit

Myth: "If you stop, you'll definitely regain everything."
Fact: Rebound is common, but it's physiology you can work with — not a sentence. That gap is exactly what a system closes.
Myth: "GLP-1 melts fat, so you're set."
Fact: Rapid loss also costs muscle. Protecting it is what protects your results — and your face.
Myth: "One kilo of muscle burns a huge amount of calories."
Fact: Muscle burns modestly (~13 kcal/kg/day). It matters — just not the inflated number marketers love.
Myth: "'Ozempic face' means you're aging fast."
Fact: It's volume lost too quickly, not age — and it can be worked on.

Now that you understand it — what's your plan for after?

Take the free 2-minute diagnostic. We'll show you what's likely happening in your case, and the exact path built for it.

Start my free diagnostic →